 TUSTIN, Calif., June 22, 2021 GLOBE NEWSWIRE -- Avid Bioservices, Inc. NASDAQ:CDMO, a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the quarter and fiscal year FY ended April 30, 2021 on June 29, 2021 after market close and will host a conference call and webcast at 1:30 PM Pacific Time 4:30 PM Eastern Time. Members of Avids senior management will discuss financial results for the quarter and FY ended April 30, 2021 and review recent corporate developments. 